FIELD: medicine.
SUBSTANCE: what is presented is a diagnostic technique for Parkinson disease in the patients with olfactory dysfunction. The suffered acute respiratory viral infection accompanied by hyperthermia is followed by stating the olfactory dysfunction. An examination complex containing determining alleles IL-1β(-511) "2/2", "1/2", HLA-DRA rs3129882 SNP, higher induction of IL-iβ production, polysomnography findings is used. If observing a carriageship of alleles IL-lβ(-511) "2/2", "1/2", HLA-DRA rs3129882 SNP, higher serum cytokine production, REM-sleep behavioral disorder, in the patients with hypo or anosmia, Parkinson disease is diagnosed.
EFFECT: invention provides diagnosing Parkinson disease at the early stages of the disease.
8 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN CHRONIC PURULENT RHINOSINUSITIS | 2008 |
|
RU2379050C2 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2009 |
|
RU2408385C1 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
METHOD FOR PROGNOSIS OF TREATMENT EFFECTIVENESS WITH RECOMBINANT CYTOKINE REGULATING INFLAMMATION | 2004 |
|
RU2271827C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
METHOD OF DETERMINATION OF PREDISPOSITION TO ALZHEIMER'S DISEASE | 2003 |
|
RU2337142C2 |
METHOD FOR PREDICTING THE EFFICIENCY OF THERAPY WITH INTERLEUKIN-1 | 2005 |
|
RU2301012C2 |
TREATMENT OF ALZHEIMER'S DISEASE WITH CYTOKINES | 2003 |
|
RU2519651C2 |
METHOD FOR DETECTION OF PRIMARY REFRACTORY FORM OF MULTIPLE MYELOMA AT THE DISEASE ONSET | 2020 |
|
RU2749612C1 |
Authors
Dates
2013-03-27—Published
2011-12-26—Filed